A Trial of Personalized Acupuncture, Fixed Acupuncture, Letrozole and Placebo on Live Birth in Women With PCOS
Status:
Recruiting
Trial end date:
2022-10-01
Target enrollment:
Participant gender:
Summary
This study is a randomized assessor-blind controlled trial. A total of 1,100 women with PCOS
will be recruited from 28 hospitals and randomly allocated into four groups: personalized
acupuncture, fixed acupuncture, letrozole or placebo letrozole. Patients will receive
treatment for 16 weeks and the primary outcome is live birth.